eyestock logo

eyestock

Markets
Catalog
Exchange: XSTO
Sector: Healthсare
Ticker: HNSA.ST

HN

Hansa Biopharma ABSTO Hansa Biopharma Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

—

Market cap $B

0.284

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

Return on assets ROA

-79 %

Last period ROA

-42%

ROA has decreased in 5 years

‌

What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

See also Hansa Biopharma

Company Analysis

HNSA.ST valuation, rating, competitors, insights and company profile

Eyestock Rating

HNSA.ST financial analysis by Eyestock methodology

Valuation

HNSA.ST valuation using historical relative method

Statements

HNSA.ST Income Statements, Balance Sheet and Cash Flow Statements

Dividends

HNSA.ST dividend yield and annual dividend

What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

What is ROA of Hansa Biopharma ?

Hansa Biopharma`s ROA for the last twelve months ended 2024-06-30 is -79 %

View Full Company Analysis
Watchlist

Discover

Stock AnalysisScreenerPortfolio